WallStreetZenWallStreetZen

NASDAQ: SLS
Sellas Life Sciences Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SLS

Based on 1 analyst offering 12 month price targets for Sellas Life Sciences Group Inc

Min Forecast
$10.00+102.84%
Avg Forecast
$10.00+102.84%
Max Forecast
$10.00+102.84%

Should I buy or sell SLS stock?

Based on 1 analyst offering ratings for Sellas Life Sciences Group Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SLS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SLS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SLS stock forecasts and price targets.

SLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-12

1 of 1

Forecast return on equity

Is SLS forecast to generate an efficient return?

Company
419.72%
Industry
67.94%
Market
159.1%
SLS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SLS forecast to generate an efficient return on assets?

Company
379.68%
Industry
31.34%
SLS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SLS earnings per share forecast

What is SLS's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.25
Avg 2 year Forecast
-$0.24
Avg 3 year Forecast
-$0.15

SLS revenue forecast

What is SLS's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$21.9M
Avg 2 year Forecast
$46.2M
Avg 3 year Forecast
$124.9M

SLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLS$4.93$10.00+102.84%Strong Buy
CGEM$14.74$32.80+122.52%Strong Buy
MRVI$3.41$4.50+31.96%Strong Buy
OMER$12.54$38.00+203.03%Strong Buy
TBPH$16.78$19.00+13.23%Buy
View Top Biotech Stocks

Sellas Life Sciences Group Stock Forecast FAQ

Is Sellas Life Sciences Group Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SLS) stock is to Strong Buy SLS stock.

Out of 1 analyst, 1 (100%) are recommending SLS as a Strong Buy, 0 (0%) are recommending SLS as a Buy, 0 (0%) are recommending SLS as a Hold, 0 (0%) are recommending SLS as a Sell, and 0 (0%) are recommending SLS as a Strong Sell.

If you're new to stock investing, here's how to buy Sellas Life Sciences Group stock.

What is SLS's earnings growth forecast for 2026-2028?

(NASDAQ: SLS) Sellas Life Sciences Group's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.95%.

Sellas Life Sciences Group's earnings in 2026 is -$26,863,000.On average, 4 Wall Street analysts forecast SLS's earnings for 2026 to be -$44,626,270, with the lowest SLS earnings forecast at -$51,396,533, and the highest SLS earnings forecast at -$37,712,341. On average, 4 Wall Street analysts forecast SLS's earnings for 2027 to be -$42,614,945, with the lowest SLS earnings forecast at -$43,997,731, and the highest SLS earnings forecast at -$41,483,575.

In 2028, SLS is forecast to generate -$26,308,847 in earnings, with the lowest earnings forecast at -$43,997,731 and the highest earnings forecast at -$7,542,468.

What is SLS's revenue growth forecast for 2026-2028?

(NASDAQ: SLS) Sellas Life Sciences Group's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.39%.

Sellas Life Sciences Group's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast SLS's revenue for 2026 to be $3,932,319,623, with the lowest SLS revenue forecast at $3,815,411,367, and the highest SLS revenue forecast at $4,088,017,715. On average, 3 Wall Street analysts forecast SLS's revenue for 2027 to be $8,296,355,754, with the lowest SLS revenue forecast at $7,786,700,409, and the highest SLS revenue forecast at $8,907,116,088.

In 2028, SLS is forecast to generate $22,424,476,015 in revenue, with the lowest revenue forecast at $17,898,815,568 and the highest revenue forecast at $27,445,604,784.

What is SLS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: SLS) forecast ROA is 379.68%, which is higher than the forecast US Biotechnology industry average of 31.34%.

What is SLS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SLS price target, the average SLS price target is $10.00, with the highest SLS stock price forecast at $10.00 and the lowest SLS stock price forecast at $10.00.

The Wall Street analyst predicted that Sellas Life Sciences Group's share price could reach $10.00 by Mar 12, 2027. The average Sellas Life Sciences Group stock price prediction forecasts a potential upside of 102.84% from the current SLS share price of $4.93.

What is SLS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: SLS) Sellas Life Sciences Group's current Earnings Per Share (EPS) is -$0.25. On average, analysts forecast that SLS's EPS will be -$0.25 for 2026, with the lowest EPS forecast at -$0.29, and the highest EPS forecast at -$0.21. On average, analysts forecast that SLS's EPS will be -$0.24 for 2027, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.23. In 2028, SLS's EPS is forecast to hit -$0.15 (min: -$0.25, max: -$0.04).

What is SLS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: SLS) forecast ROE is 419.72%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.